Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Common Stock · CUSIP: 03969T109

Event date: 2025-06-30

Filing-level shares
1,810,165
Percent of class
6.67%
  • The Vanguard Group

    Shares: 1,810,165 · Class: 6.67%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000838
Form type
SCHEDULE 13G/A
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub